You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Grade 3 Glioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

High Grade Glioma Trial (177Lu-PSMA I&T)

Not yet recruiting
  • High Grade Glioma
  • 177Lu-PSMA I&T
  • (no location specified)
Dec 1, 2022

Low-grade Glioma Trial in Toronto (Saturation Transfer (ST)-MRI)

Recruiting
  • Low-grade Glioma
  • Saturation Transfer (ST)-MRI
  • Toronto, Ontario, Canada
  • +1 more
Aug 10, 2023

Glioblastoma Multiforme, Adult Trial (Adaptive, two-phase RT)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Adaptive, two-phase RT
  • (no location specified)
Feb 8, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

    Not yet recruiting
    • Low-grade Glioma
    • (no location specified)
    Oct 3, 2022

    Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

    Recruiting
    • Glioma
    • +4 more
    • 3T MRI scanner
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)

    Not yet recruiting
    • Malignant Glioma
    • Glioblastoma
    • hEGFRvIII-CD3 (BRiTE)
    • Activated Cell Therapy
    • Durham, North Carolina
      Duke University Medical Center
    Jun 24, 2022

    High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

    Not yet recruiting
    • High Grade Glioma
    • +8 more
    • Aurora, Colorado
    • +17 more
    May 2, 2023

    Glioblastoma Multiforme Trial in Toronto (Reduced margin adaptive radiotherapy)

    Recruiting
    • Glioblastoma Multiforme
    • Reduced margin adaptive radiotherapy
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Oct 19, 2022

    Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

    Recruiting
    • Recurrent High-grade Glioma
    • +3 more
    • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
    • +2 more
    • Incheon, Korea, Republic of
      Gachon University Gil Medical Center
    Feb 19, 2023

    High Grade Glioma Trial in Cleveland (procedure, radiation, drug)

    Recruiting
    • High Grade Glioma
    • LITT
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
    Jan 5, 2023

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

    Not yet recruiting
    • Central Nervous System Neoplasms
    • +6 more
    • B7-H3-CAR T cells
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 18, 2023

    Glioma Trial in Philadelphia (ONC201)

    No longer available
    • Glioma
    • Philadelphia, Pennsylvania
      Oncoceutics
    Mar 10, 2022

    High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

    Recruiting
    • High Grade Glioma
    • Diffuse Intrinsic Pontine Glioma
    • Aurora, Colorado
    • +17 more
    Aug 10, 2022

    Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

    Active, not recruiting
    • Low-grade Glioma
    • +2 more
    • Calgary, Alberta, Canada
    • +6 more
    Oct 25, 2022

    Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma

    Recruiting
    • Recurrent Glioblastoma Multiforme (GBM)
    • +3 more
    • Los Angeles, California
    • +4 more
    May 5, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

    Terminated
    • Low Grade Glioma
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Nov 3, 2021

    Glioma Trial in United States (ONC201)

    Active, not recruiting
    • Glioma
    • San Francisco, California
    • +8 more
    Jul 14, 2022

    Glioma, IDH Mutation Trial (BAY 2402234)

    Withdrawn
    • Glioma
    • IDH Mutation
    • BAY 2402234
    • (no location specified)
    Dec 17, 2021

    Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

    Not yet recruiting
    • Advanced Solid Tumor
    • +2 more
    • Palo Alto, California
    • +9 more
    Aug 2, 2022

    Glioma Trial in Ottawa (MR perfusion imaging)

    Completed
    • Glioma
    • MR perfusion imaging
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Oct 7, 2021

    Glioblastoma Trial in Toronto (Focused Ultrasound (FUS) BBB Disruption)

    Active, not recruiting
    • Glioblastoma
    • Focused Ultrasound (FUS) BBB Disruption
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Mar 28, 2022